“There are intense, ongoing research efforts to understand the connection between the microbiome and human health, with an eye towards developing novel therapies,” states this article in Pharmaceutical Patent Analyst.

“Consequently, many new discoveries will surely result, but as will be discussed … there are unique challenges for obtaining commercially meaningful patent protection for these discoveries.”

Authors of the article include Anthony D. Sabatelli, a member of CURE’s Board of Directors.